Search results for "Atrial Fibrillation"
RSV vaccine, OTC naloxone approved
The FDA also updated the prescribing information for immediate-release opioid pain medicines to note that these products should not be used for an extended period, among other recent actions.
https://acphospitalist.acponline.org/archives/2023/05/24/rsv-vaccine-otc-naloxone-approved.htm
24 May 2023
Catheters recalled; warning on troponin tests
The FDA announced a recall of certain peripheral catheters due to leaking and warned not to use a cardiac testing panel providing inaccurate troponin measurements, among other recent actions.
https://acphospitalist.acponline.org/archives/2023/08/02/catheters-recalled-warning-on-troponin-tests.htm
2 Aug 2023
November 2019
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2019/11/
Hospital performance on one stroke quality measure may predict performance on others
Hospitals that performed well on one of four indicators—carotid imaging, antithrombolytic therapy, treatment in a stroke unit, or discharge to inpatient rehabilitation—tended to also perform well on the other three, and the reverse was also true, with poor performance on one predicting poor performance on the others.
https://acphospitalist.acponline.org/weekly/archives/2020/12/09/4.htm
9 Dec 2020
MKSAP quiz on stroke
This month's quiz includes questions from ACP's Medical Knowledge Self-Assessment Program (MKSAP 18) on stroke.
https://acphospitalist.acponline.org/archives/2020/08/mksap-quiz-on-stroke.htm
15 Aug 2020
New antibiotic approved for hospital-acquired pneumonia
The FDA approved sulbactam and durlobactam for injection to treat hospital-acquired or ventilator-associated pneumonia caused by susceptible strains of Acinetobacter baumannii-calcoaceticus complex, among other recent actions.
https://acphospitalist.acponline.org/archives/2023/07/05/new-antibiotic-approved-for-hospital-acquired-pneumonia.htm
5 Jul 2023
Interrupting DOACs for surgery associated with low rates of major bleeding, clots in afib patients
The standardized strategy stopped direct oral anticoagulants (DOAC) for one to two days prior to an elective surgery or procedure and resumed DOACs one to three days afterward, without heparin bridging, in patients with atrial fibrillation.
https://acphospitalist.acponline.org/weekly/archives/2019/08/14/3.htm
14 Aug 2019
Switching to newer oral anticoagulant didn't benefit frail older patients with afib
A randomized trial that switched some frail atrial fibrillation patients from vitamin K antagonists (VKAs) to non-vitamin K oral anticoagulants found that such patients had more bleeding and no decrease in thromboembolic events compared to those who stayed on a VKA.
https://acphospitalist.acponline.org/archives/2023/09/06/switching-to-newer-oral-anticoagulant-didnt-benefit-frail-older-patients-with-afib.htm
6 Sep 2023
In-hospital mortality for afib patients appears higher in rural vs. urban hospitals
The electrophysiology and medical communities should look at the findings as a motivational call to initiate prospective studies with the goal of identifying gaps in afib care, an accompanying editorial said.
https://acphospitalist.acponline.org/weekly/archives/2017/12/20/3.htm
20 Dec 2017
Bridging with heparin after stroke associated with worse outcomes than not bridging
Both ischemic and bleeding events within 90 days of stroke were more common among patients with nonvalvular atrial fibrillation who received full-dose low-molecular-weight heparin when starting a direct oral anticoagulant or warfarin.
https://acphospitalist.acponline.org/weekly/archives/2019/07/03/2.htm
3 Jul 2019